VGX-1027 | B1632

VGX-1027(GIT27) is an orally active immunomodulatory agent and a isoxazole compound that exhibits various immunomodulatory properties; reduce the secretion of IL-1beta, TNF-alpha and IL-10 from purified murine macrophages.

VGX-1027(GIT27) is an orally active immunomodulatory agent and a isoxazole compound that exhibits various immunomodulatory properties; reduce the secretion of IL-1beta, TNF-alpha and IL-10 from purified murine macrophages.

B1632 | VGX-1027 DataSheet

Alternate Name/Synonyms: VGX-1027; VGX1027; VGX 1027; GIT-27; GIT 27; GIT27; 2-(3-phenyl-4,5-dihydro-1,2-oxazol-5-yl)acetic acid

Appearance: Solid

Formulation: N/A

CAS Number: 6501-72-0

Structure Available?: Yes

Peptide sequence: N/A

Salt Form: No

Molecular Formula: C₁₁H₁₁NO₃

Molecular Weight: 205.21

Cell-Permeable?: Yes

Purity: >98%

Solubilities: DMSO

Handling: Protect from air and light

Country of Origin: USA

Tag Line: An orally active immunomodulatory agent

MDL Number: MFCD08696167

PubChem CID: 10798271

SMILES: C1C(ON=C1C2=CC=CC=C2)CC(=O)O

InChi: 1S/C11H11NO3/c13-11(14)7-9-6-10(12-15-9)8-4-2-1-3-5-8/h1-5,9H,6-7H2,(H,13,14)

InChi Key: MUFJHYRCIHHATF-UHFFFAOYSA-N